| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/06/2005 | CN1195511C The use of fumaric acid derivatives in transplant medicine |
| 04/06/2005 | CN1195502C Periadventitial delivery device |
| 04/06/2005 | CN1195499C Enteric coated pharmaceutical tablet and method of manufacturing |
| 04/06/2005 | CN1195495C Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/05/2005 | US6875853 Immunization of dairy cattle with chimeric GapC protein against streptococcus infection |
| 04/05/2005 | US6875849 Methods of recovering chaperone proteins and complexes thereof |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |
| 04/05/2005 | US6875845 Polypeptide for use in the treatment of cancer |
| 04/05/2005 | US6875844 Recombinant or chemically synthesized intestinal carboxyesterase (ICE)amino acid sequences for treating solid tumors |
| 04/05/2005 | US6875843 Reducing the rate of islet cell infiltration by lymphocytes in a diabetes-susceptible mammal by administering a gonadotropin-releasing hormone antagonist. |
| 04/05/2005 | US6875767 (5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors |
| 04/05/2005 | US6875755 Antithrombotic compound |
| 04/05/2005 | US6875749 Methods of facilitating vascular growth |
| 04/05/2005 | US6875748 Sodium and potassium phosphate salts, in aqueous solution, and detergents and surfactants for direct polypeptide delivery into vertebrate cells |
| 04/05/2005 | US6875747 Antisense to c-myc for treatment of polycystic kidney disease |
| 04/05/2005 | US6875745 Synergistic mixture of lapachone and taxane; anticancer, antitumor agents |
| 04/05/2005 | US6875744 Short bioactive peptides |
| 04/05/2005 | US6875743 Antiinflammatory agents; autoimmune disease |
| 04/05/2005 | US6875742 Method for treating cytokine mediated hepatic injury |
| 04/05/2005 | US6875741 Insulin and IGF-1 receptor agonists and antagonists |
| 04/05/2005 | US6875740 Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens |
| 04/05/2005 | US6875738 Therapeutic chemokine receptor antagonists |
| 04/05/2005 | US6875737 Multivalent compounds for crosslinking receptors and uses thereof |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | US6875611 Soluble steroidal peptides for nucleic acid delivery |
| 04/05/2005 | US6875606 Human α-7 nicotinic receptor promoter |
| 04/05/2005 | US6875599 Enzymatic protein for use in the treatment of inflammation, cancers, cardiovascular, brain, respiratory and crohn's disease |
| 04/05/2005 | US6875598 Histone deacetylase-8 proteins, nuclei acids, and methods for use |
| 04/05/2005 | US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 04/05/2005 | US6875589 Preparing mono-arginyl-insulin for treatment of diabetes; antidiabetic agents |
| 04/05/2005 | US6875581 Identifying agonist and/or antagonist of calcium calmodulin-dependent protein kinases using laser fluctuation correlation spectroscopy; peptide mimetics; immunosuppressants |
| 04/05/2005 | US6875571 NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | US6875569 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression |
| 04/05/2005 | US6875567 Identifying genes associated with hypertrophic cardiac tissue for diagnosis, prognosis, prevention and treatment of cardiovascular disorders |
| 04/05/2005 | US6875451 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 04/05/2005 | US6875446 Method for prophylaxis and/or treatment of thromboembolism |
| 04/05/2005 | US6875441 Composition for delivery of hematopoietic growth factor |
| 04/05/2005 | US6875435 In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 04/05/2005 | US6875434 Methods of treatment of Alzheimer's disease |
| 04/05/2005 | US6875432 Reduced-viscosity concentrated protein formulations |
| 04/05/2005 | US6875431 Therapy of bacterial infections by the use of a lysing enzyme blended with an appropriate carrier |
| 04/05/2005 | US6875427 Bonding, sealing using lasers; using water soluble collagen |
| 04/05/2005 | CA2276146C Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 04/05/2005 | CA2235138C Reverse-turn mimetics and methods relating thereto |
| 04/05/2005 | CA2232344C Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/05/2005 | CA2147749C Therapeutic agent for diseases of periodontal tissue |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 04/03/2005 | CA2480616A1 Specific markers for diabetes |
| 03/31/2005 | WO2005029090A1 Elastin peptide fingerprints and analysis methods for mmp12 related to copd |
| 03/31/2005 | WO2005029066A2 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 03/31/2005 | WO2005029035A2 Methods of screening compositions for g protein-coupled receptor agonist activity |
| 03/31/2005 | WO2005029034A2 Methods for the identification of inhibitors of amidophosphoribosyltransferase and cutinase transcription factor 1 as antibiotics |
| 03/31/2005 | WO2005028673A1 A method for detecting nipah virus and method for providing immunoprotection against henipaviruses |
| 03/31/2005 | WO2005028650A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 03/31/2005 | WO2005028628A2 Modulation of eif4e expression |
| 03/31/2005 | WO2005028620A2 Histone modifications as binary switches controlling gene expression |
| 03/31/2005 | WO2005028517A2 SOLUBLE TGF-β TYPE III RECEPTOR FUSION PROTEINS |
| 03/31/2005 | WO2005028516A2 Albumin-binding derivatives of therapeutic peptides |
| 03/31/2005 | WO2005028503A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | WO2005028502A1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 03/31/2005 | WO2005028501A1 Macrocyclic peptides active against the hepatitis c virus |
| 03/31/2005 | WO2005028499A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 03/31/2005 | WO2005028497A2 Receptor binding peptides derived from the sars s protein |
| 03/31/2005 | WO2005027978A2 Albumin-binding derivatives of therapeutic peptides |
| 03/31/2005 | WO2005027969A1 Remedy for eye diseases accompanied by optic nerve injuries |
| 03/31/2005 | WO2005027960A1 Liquid human growth hormone formulation containing polyethylene glycol |
| 03/31/2005 | WO2005027959A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization. |
| 03/31/2005 | WO2005027958A1 Thymosin-beta-sulphoxide as an immunosuppressive active agent |
| 03/31/2005 | WO2005027957A1 Multiple-arm peptide compounds, methods of manufacture and use in therapy |
| 03/31/2005 | WO2005027956A1 Method of treating allergy and/or airway disease |
| 03/31/2005 | WO2005027955A1 Oral compositions for the stimulation of gastric acid secretion comprising pentagastrin |
| 03/31/2005 | WO2005027954A2 Sincalide formulations |
| 03/31/2005 | WO2005027953A2 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 03/31/2005 | WO2005027935A1 Carbohydrate composition and its use for the preparation of a medicament for treating or preventing pulmonary inflammation or acute respiration distress syndrome |
| 03/31/2005 | WO2005027926A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bone morphogenetic protein |
| 03/31/2005 | WO2005027915A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 03/31/2005 | WO2005027895A2 Thyroid hormone analogs and methods of use in angiogenesis |
| 03/31/2005 | WO2005027894A1 Enhanced method of treatment of growth disorders |
| 03/31/2005 | WO2005027884A2 Stabilized ocular solutions |
| 03/31/2005 | WO2005027871A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 03/31/2005 | WO2005027850A2 Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
| 03/31/2005 | WO2005027839A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 03/31/2005 | WO2005027827A2 Host defense factor x (hdfx) |
| 03/31/2005 | WO2005027629A2 Regulation of cardiac contractility and heart failure propensity |
| 03/31/2005 | WO2005027628A1 Receptor |
| 03/31/2005 | WO2005019259A3 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 03/31/2005 | WO2005009355A3 Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy |
| 03/31/2005 | WO2005005632A3 SMALL INTERFERING RNA SPECIFIC TO SUB-UNITS $G(A), $G(A)' AND $G(B) OF THE KINASE PROTEIN CK2, AND THE APPLICATIONS OF THE SAME |
| 03/31/2005 | WO2005004894A3 Methods for increasing cell and tissue viability |
| 03/31/2005 | WO2004110490A3 Use of vegf inhibitors for tumor regression |
| 03/31/2005 | WO2004110371A3 Method for the treatment of malignancies |
| 03/31/2005 | WO2004106532A8 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b |
| 03/31/2005 | WO2004100870A3 Compositions and methods for wt1 specific immunotherapy |
| 03/31/2005 | WO2004094605A3 Methods and compositions for inhibiting stat signaling pathways |
| 03/31/2005 | WO2004089978A3 Use of hcv proteins |
| 03/31/2005 | WO2004087744A3 Composition and method for nerve regeneration |
| 03/31/2005 | WO2004087736A3 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip) |
| 03/31/2005 | WO2004085682A3 Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza |
| 03/31/2005 | WO2004085664B1 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use |